Bioventus Inc.·4

Jun 20, 5:34 PM ET

Ladone Mary Kay 4

4 · Bioventus Inc. · Filed Jun 20, 2023

Insider Transaction Report

Form 4
Period: 2023-06-16
Transactions
  • Exercise/Conversion

    Class A Common Stock

    2023-06-16+1,81320,274 total
  • Exercise/Conversion

    Restricted Stock Units

    2023-06-161,8131,814 total
    Class A Common Stock (1,813 underlying)
Footnotes (2)
  • [F1]Each restricted stock unit ("RSU") represents a contingent right to receive one share of Class A common stock.
  • [F2]1,813 RSUs vested on June 16, 2023. The remaining 1,814 RSUs shall vest and become exercisable on June 16, 2024, subject to the Reporting Person continuing in service on the Issuer's Board of Directors through the applicable vesting date.

Documents

1 file
  • 4
    primary_doc.xmlPrimary

    PRIMARY DOCUMENT